|
Advanced Oncotherapy PLC - London-based particle therapy for cancer treatment - Receives balance of funds, about £1.2 million, due under the secured convertible loan agreements entered into by the company with investors and directors. The balance of funds that have been received by the company includes £500,000 that was due to be received from Executive Chair Michael Sinclair by mid-March 2023. Currently, £5.0 million has been received from investors under the secured convertible loan note. Says it is also taking steps to raise additional financing. Current stock price: 4.13 pence, down 2.9% in London on Monday afternoon 12 month change: down 82% Copyright 2023 Alliance News Ltd. All Rights Reserved.
|
